A sensitive method for determining levels of [-]-2,5,-dimethoxy-4-methylamphetamine in the brain tissue.
Justin R Eckler, H Greizerstein, R A Rabin, Jerrold C Winter
Journal of pharmacological and toxicological methods 2001 DOI: 10.1016/s1056-8719(02)00159-4 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Method development study Peer reviewed |
|---|---|
| Population | Rat brain tissue |
| Key points | The analytical method achieved over 90% recovery and reliable precision, accuracy, and linearity. In rats, peak brain levels of (-)-DOM did not coincide with the 75-minute pretreatment time established by drug-induced stimulus control. |
Abstract
Indolamine and phenethylamine hallucinogens are drugs of abuse and, as well, mimic some aspects of idiopathic psychosis. To assist in investigating the mechanisms of action of (-)2,5-dimethoxy4-methylamphetamine ([-]-DOM), a member of the phenethylamine class of serotonergic hallucinogens, a sensitive and precise method for determining its levels in the brain tissue is required. We now describe a method for determining nanogram quantities of [-]-DOM in the rat brain tissue using D-amphetamine as an intemal standard. The method employs solvent extraction with toluene and derivatization with trifluoroacetic acid anhydride (TFAA) followed by analysis using gas chromatography-mass spectrometry (GS-MS) in the selective ion monitoring (SIM) mode. With SIM detection, our overall recoveries were greater than 90%. The method was reliable in terms of within-day and between-day precision, accuracy, and linearity. The procedure was applied to animal subjects to determine the in vivo [-]-DOM brain levels following intraperitoneal (ip) administration. Our findings indicate that peak levels of [-]-DOM do not coincide with the 75-min pretreatment time established by drug-induced stimulus control. This study demonstrates a sensitive and precise analytical method for the determination of [-]-DOM levels in the rat brain following systemic administration of behaviorally relevant doses.
Citations in the library
Cited by 6
- Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics February 1, 2008
- Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology November 1, 2008
- A 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat. Pharmacology, Biochemistry, and Behavior September 2004
- Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM. Pharmacology, Biochemistry, and Behavior July 2003
- Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD. Pharmacology, Biochemistry, and Behavior February 2003
and 1 more in the library
Cites 8
- 2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug Science November 3, 1967
- DOM (STP), a New Hallucinogenic Drug, and DOET: Effects in Normal Subjects American Journal of Psychiatry September 1, 1968
- Acquired and Crossed Tolerance to Mescaline, LSD-25, and BOL-148 Archives of General Psychiatry September 1, 1959
- Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli Psychopharmacology 1971
- The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens. Pharmacology, Biochemistry, and Behavior July 1, 1999
and 3 more in the library